Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Teva
Fish and Richardson
Daiichi Sankyo
UBS
QuintilesIMS
US Army
Colorcon
Mallinckrodt

Generated: July 22, 2018

DrugPatentWatch Database Preview

Aminoglutethimide - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for aminoglutethimide and what is the scope of aminoglutethimide patent protection?

Aminoglutethimide
is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for aminoglutethimide
Medical Subject Heading (MeSH) Categories for aminoglutethimide
Synonyms for aminoglutethimide
.alpha.-(p-Aminophenyl)-.alpha.-ethylglutarimide
( inverted question mark)-p-Aminoglutethimide
(?)-p-Aminoglutethimide
(+-)-3-(p-Aminophenyl)-3-ethyl-2,6-piperidinedione
(+/-)-p-AMINOGLUTETHIMIDE
(A+/-)-p-Aminoglutethimide
(inverted question mark)-p-Aminoglutethimide
(RS)-2-(4-Amino-phenyl)-2-ethyl-glutarimide;(RS)-3-(4-Amino-phenyl)-3-ethyl-2,6-dioxo-piperidine
(y)-p-Aminoglutethimide
125-84-8
125A848
2-(4-aminophenyl)-2-ethylglutarimide
2-(p-Aminophenyl)-2-ethylglutarimide
2, 3-(4-aminophenyl)-3-ethyl-
2,6-Piperidinedione, 3-(4-aminophenyl)-3-ethyl-
3-(4-Aminophenyl)-3-ethyl-2,6-piperidindion
3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione
3-(4-aminophenyl)-3-ethyl-piperidine-2,6-dione
3-(4-aminophenyl)-3-ethylazaperhydroine-2,6-dione
3-(4-aminophenyl)-3-ethylpiperidine-2,6-dione
3-(p-Aminophenyl)-3-ethylpiperidine-2,6-dione
3-Ethyl-3-(p-aminophenyl)-2,6-dioxopiperidine
A 9657
A805433
AB00051935
AB00051935_12
AB00051935_13
AB00051935-09
AB00051935-11
AB0013271
AB2000209
AC-12456
AC1L1D0R
AC1Q2SPJ
AG-1
AKOS004120070
AKOS022060651
alpha-(p-Aminophenyl)-alpha-ethylglutarimide
Aminoglutethimid
aminoglutethimide (AG)
Aminoglutethimide (Cytadren)
Aminoglutethimide (USP/INN)
Aminoglutethimide [INN:BAN]
Aminoglutethimide [USP:INN:BAN]
Aminoglutethimide AG, 4
Aminoglutethimide, European Pharmacopoeia (EP) Reference Standard
Aminoglutethimide, United States Pharmacopeia (USP) Reference Standard
Aminoglutethimidum
Aminoglutethimidum [INN-Latin]
Aminoglutetimida
Aminoglutetimida [INN-Spanish]
Aminoglutetimide
AN-43553
AS-13282
AT-2947
Ba 16038
Ba-16038
BB_SC-1153
BBL010961
BDBM9460
BPBio1_000032
BRD-A25234499-001-05-0
BRN 0210656
BSPBio_000028
BSPBio_001832
C 16038-BA
C07617
CAS-125-84-8
CCG-38911
CCRIS 7562
CHEBI:2654
CHEMBL488
Ciba Vision Brand of Aminoglutethimide
CPD000326785
CS-2205
CTK6D0224
Cytadren
Cytadren (TN)
D00574
D0M6DO
DB-021640
DB00357
DivK1c_000884
dl-Aminoglutethimide
DSSTox_CID_2589
DSSTox_GSID_22589
DSSTox_RID_76647
DTXSID8022589
EBD40055
EINECS 204-756-4
Elipten
EN300-53368
EU-0100124
FT-0622284
Glutarimide, 2-(p-aminophenyl)-2-ethyl-
Glutethimide, para-amino
GTPL7054
H801
HE003306
HE352330
HMS1568B10
HMS1920C09
HMS2090I05
HMS2091I09
HMS2095B10
HMS2231M19
HMS3259H10
HMS3260I10
HMS3372M07
HMS3655O17
HMS502M06
HSDB 7494
HY-B0237
IDI1_000884
K-1913
KBio1_000884
KBio2_000400
KBio2_002968
KBio2_005536
KBio3_001332
KBioGR_000588
KBioSS_000400
Lopac0_000124
LP00124
LS-72014
MCULE-9118268281
MFCD00010122
MLS000859924
MLS001213216
NC00714
NCGC00015110-02
NCGC00015110-03
NCGC00015110-04
NCGC00015110-05
NCGC00015110-06
NCGC00015110-07
NCGC00015110-09
NCGC00015110-12
NCGC00016379-01
NCGC00093615-01
NCGC00093615-02
NCGC00093615-03
NCGC00093615-04
NCGC00093615-05
NCGC00257263-01
NCGC00260809-01
NCI60_002900
NINDS_000884
Novartis Brand of Aminoglutethimide
NSC-330915
NSC-755868
NSC330915
NSC755868
Orimeten
p-Aminoglutethimide
Pharmakon1600-01500115
Prestwick_243
Prestwick0_000244
Prestwick1_000244
Prestwick2_000244
Prestwick3_000244
ROBVIMPUHSLWNV-UHFFFAOYSA-N
S1672
SAM002589964
SBB000711
SBI-0050112.P004
SC-12125
SCHEMBL4306
SMP1_000017
SMR000326785
SPBio_000046
SPBio_002247
Spectrum_000040
SPECTRUM1500115
Spectrum2_000093
Spectrum3_000296
Spectrum4_000144
Spectrum5_000802
SR-01000075596
SR-01000075596-1
STK802074
Tox21_110406
Tox21_110406_1
Tox21_303497
Tox21_500124
VU0243029-3
W-108399
Z1259341083

US Patents and Regulatory Information for aminoglutethimide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis CYTADREN aminoglutethimide TABLET;ORAL 018202-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for aminoglutethimide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis CYTADREN aminoglutethimide TABLET;ORAL 018202-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis CYTADREN aminoglutethimide TABLET;ORAL 018202-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Mallinckrodt
Fish and Richardson
Harvard Business School
McKinsey
Federal Trade Commission
US Department of Justice
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.